Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[The TULUNG clinical registry].
Spelda S, Skřičková J, Bortlíček Z, Hejduk K, Pešek M, Zatloukal P, Kolek V, Salajka F, Koubková L, Tomíšková M, Grygárková Y, Havel L, Hrnčiarik M, Zemanová M, Sixtová D, Roubec J, Coupková H, Košatová K. Spelda S, et al. Among authors: pesek m. Klin Onkol. 2012;25(5):383-4. Klin Onkol. 2012. PMID: 23102201 Czech. No abstract available.
[TARCEVA Clinical Registry].
Skricková J, Pesek M, Zatloukal P, Kolek V, Salajka F, Koubková L, Krejcí J, Tomísková M, Grygárková Y, Havel L, Hrnciarik M, Skalová B, Stícha M. Skricková J, et al. Among authors: pesek m. Klin Onkol. 2010;23(5):361-3. Klin Onkol. 2010. PMID: 21061685 Czech. No abstract available.
Real-life effectiveness of first-line anticancer treatments in stage IIIB/IV NSCLC patients: Data from the Czech TULUNG Registry.
Brat K, Bratova M, Skrickova J, Barinova M, Hurdalkova K, Pesek M, Havel L, Koubkova L, Hrnciarik M, Krejci J, Fischer O, Zemanova M, Coupkova H, Svaton M. Brat K, et al. Among authors: pesek m. Thorac Cancer. 2020 Nov;11(11):3346-3356. doi: 10.1111/1759-7714.13679. Epub 2020 Oct 5. Thorac Cancer. 2020. PMID: 33016001 Free PMC article.
[EGFR mutations in patients with advanced NSCLC].
Fiala O, Pešek M, Fínek J, Brůha F, Bortlíček Z, Krejčí J, Benešová L, Minárik M. Fiala O, et al. Among authors: pesek m. Klin Onkol. 2012;25(4):267-73. Klin Onkol. 2012. PMID: 22920167 Czech.
[Radiotherapy of Lung Tumours in Idiopathic Pulmonary Fibrosis].
Kolek V, Vašáková M, Šterclová M, Cwiertka K, Vrána D, Kudláček A, Skřičková J, Pešek M, Petera J. Kolek V, et al. Among authors: pesek m. Klin Onkol. 2017 Summer;30(4):303-306. doi: 10.14735/amko2017303. Klin Onkol. 2017. PMID: 28832178 Review. Czech.
Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial.
Zatloukal P, Petruzelka L, Zemanová M, Kolek V, Skricková J, Pesek M, Fojtů H, Grygárková I, Sixtová D, Roubec J, Horenková E, Havel L, Průsa P, Nováková L, Skácel T, Kůta M. Zatloukal P, et al. Among authors: pesek m. Lung Cancer. 2003 Sep;41(3):321-31. doi: 10.1016/s0169-5002(03)00233-2. Lung Cancer. 2003. PMID: 12928123 Clinical Trial.
Autologous dendritic cell-based immunotherapy (DCVAC/LuCa) and carboplatin/paclitaxel in advanced non-small cell lung cancer: A randomized, open-label, phase I/II trial.
Zemanova M, Cernovska M, Havel L, Bartek T, Lukesova S, Jakesova J, Vanasek J, Reiterer P, Kultan J, Andrasina I, Siskova L, Koubkova L, Skrickova J, Salajka F, Pesek M, Klepetko P, Beniak J, Fricke H, Kadlecova P, Korolkiewicz RP, Hraska M, Bartunkova J, Spisek R. Zemanova M, et al. Among authors: pesek m. Cancer Treat Res Commun. 2021;28:100427. doi: 10.1016/j.ctarc.2021.100427. Epub 2021 Jun 26. Cancer Treat Res Commun. 2021. PMID: 34284344 Free article. Clinical Trial.
Erlotinib in the treatment of advanced squamous cell NSCLC.
Fiala O, Pesek M, Finek J, Krejci J, Havel L, Hrnciarik M, Salajka F, Bortlicek Z, Benesova L, Minarik M. Fiala O, et al. Among authors: pesek m. Neoplasma. 2013;60(6):676-82. doi: 10.4149/neo_2013_086. Neoplasma. 2013. PMID: 23906302
181 results